Literature DB >> 19282272

Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro.

Laura K Potter1, Dennis L Sprecher, Max C Walker, Frank L Tobin.   

Abstract

Because cholesteryl ester transfer protein (CETP) inhibition is a potential HDL-raising therapy, interest has been raised in the mechanisms and consequences of CETP activity. To explore these mechanisms and the dynamics of CETP in vitro, a mechanistic mathematical model was developed based upon the shuttle mechanism for lipid transfer. Model parameters were estimated from eight published experimental datasets, and the resulting model captures observed dynamics of CETP in vitro. Simulations suggest the shuttle mechanism yields behaviors consistent with experimental observations. Three key findings predicted from model simulations are: 1) net CE transfer activity from HDL to VLDL and LDL can be significantly altered by changing the balance of homoexchange versus heteroexchange of neutral lipids via CETP; 2) lipemia-induced increases in CETP activity are more likely caused by increases in lipoprotein particle size than particle number; and 3) the inhibition mechanisms of the CETP inhibitors torcetrapib and JTT-705 are significantly more potent than a classic competitive inhibition mechanism with the irreversible binding mechanism having the most robust response. In summary, the model provides a plausible representation of CETP activity in vitro, corroborates strong evidence for the shuttle hypothesis, and provides new insights into the consequences of CETP activity and inhibition on lipoproteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282272      PMCID: PMC2759828          DOI: 10.1194/jlr.M900015-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  38 in total

1.  Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.

Authors:  M Guérin; W Le Goff ; T S Lassel; A Van Tol ; G Steiner; M J Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-02       Impact factor: 8.311

2.  Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.

Authors:  N A Le; W Innis-Whitehouse; X Li; R Bakker-Arkema; D Black; W V Brown
Journal:  Metabolism       Date:  2000-02       Impact factor: 8.694

3.  Physical and kinetic characterization of recombinant human cholesteryl ester transfer protein.

Authors:  D T Connolly; J McIntyre; D Heuvelman; E E Remsen; R E McKinnie; L Vu; M Melton; R Monsell; E S Krul; K Glenn
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

4.  Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules.

Authors:  Xiayang Qiu; Anil Mistry; Mark J Ammirati; Boris A Chrunyk; Ronald W Clark; Yang Cong; Jeffrey S Culp; Dennis E Danley; Thomas B Freeman; Kieran F Geoghegan; Matthew C Griffor; Steven J Hawrylik; Cheryl M Hayward; Preston Hensley; Lise R Hoth; George A Karam; Maruja E Lira; David B Lloyd; Katherine M McGrath; Kim J Stutzman-Engwall; Ann K Subashi; Timothy A Subashi; John F Thompson; Ing-Kae Wang; Honglei Zhao; Andrew P Seddon
Journal:  Nat Struct Mol Biol       Date:  2007-01-21       Impact factor: 15.369

5.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

6.  The surface cholesteryl ester content of donor and acceptor particles regulates CETP: a liposome-based approach to assess the substrate properties of lipoproteins.

Authors:  Richard E Morton; Diane J Greene
Journal:  J Lipid Res       Date:  2003-05-01       Impact factor: 5.922

Review 7.  Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors.

Authors:  P J Barter
Journal:  Atheroscler Suppl       Date:  2002-12       Impact factor: 3.235

Review 8.  A review of CETP and its relation to atherosclerosis.

Authors:  Greetje J de Grooth; Anke H E M Klerkx; Erik S G Stroes; Anton F H Stalenhoef; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2004-09-01       Impact factor: 5.922

9.  Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state.

Authors:  Maryse Guerin; Pascal Egger; Céline Soudant; Wilfried Le Goff; Arie van Tol; Reynald Dupuis; M John Chapman
Journal:  J Lipid Res       Date:  2002-10       Impact factor: 5.922

Review 10.  Regulation of reverse cholesterol transport and clinical implications.

Authors:  Daniel J Rader
Journal:  Am J Cardiol       Date:  2003-08-18       Impact factor: 2.778

View more
  12 in total

1.  A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans.

Authors:  Niek C A van de Pas; Ruud A Woutersen; Ben van Ommen; Ivonne M C M Rietjens; Albert A de Graaf
Journal:  J Lipid Res       Date:  2012-09-29       Impact factor: 5.922

2.  In silico modeling of the dynamics of low density lipoprotein composition via a single plasma sample.

Authors:  Martin Jansen; Peter Pfaffelhuber; Michael M Hoffmann; Gerhard Puetz; Karl Winkler
Journal:  J Lipid Res       Date:  2016-03-25       Impact factor: 5.922

Review 3.  Cholesteryl ester transfer protein and its inhibition.

Authors:  Olaf Weber; Hilmar Bischoff; Carsten Schmeck; Michael-Friedrich Böttcher
Journal:  Cell Mol Life Sci       Date:  2010-06-18       Impact factor: 9.261

4.  Quantitative Models of Lipid Transfer and Membrane Contact Formation.

Authors:  Yongli Zhang; Jinghua Ge; Xin Bian; Avinash Kumar
Journal:  Contact (Thousand Oaks)       Date:  2022-05-04

5.  Anti-Aging and Tissue Regeneration Ability of Policosanol Along with Lipid-Lowering Effect in Hyperlipidemic Zebrafish via Enhancement of High-Density Lipoprotein Functionality.

Authors:  Eun-Young Lee; Jeong-Ah Yoo; So-Mang Lim; Kyung-Hyun Cho
Journal:  Rejuvenation Res       Date:  2016-02-12       Impact factor: 4.663

6.  A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-cholesterol in adult asymptomatic women.

Authors:  Eliane S Parra; Aline Urban; Natalia B Panzoldo; Rui T Nakamura; Rogério Oliveira; Eliana C de Faria
Journal:  Lipids Health Dis       Date:  2011-05-24       Impact factor: 3.876

7.  A computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolism.

Authors:  Fianne L P Sips; Christian A Tiemann; Maaike H Oosterveer; Albert K Groen; Peter A J Hilbers; Natal A W van Riel
Journal:  PLoS Comput Biol       Date:  2014-05-01       Impact factor: 4.475

8.  Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study.

Authors:  Chidozie Elochukwu Agu; Ikenna Kingsley Uchendu; Augusta Chinyere Nsonwu; Chukwugozie Nwachukwu Okwuosa; Peter Uwadiegwu Achukwu
Journal:  BMC Public Health       Date:  2019-08-20       Impact factor: 3.295

9.  A mathematical model to estimate cholesterylester transfer protein (CETP) triglycerides flux in human plasma.

Authors:  Martin Jansen; Gerhard Puetz; Michael M Hoffmann; Karl Winkler
Journal:  BMC Syst Biol       Date:  2019-01-22

10.  An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway.

Authors:  James Lu; Katrin Hübner; M Nazeem Nanjee; Eliot A Brinton; Norman A Mazer
Journal:  PLoS Comput Biol       Date:  2014-03-13       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.